89 related articles for article (PubMed ID: 1359494)
41. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.
Arsura M; Introna M; Passerini F; Mantovani A; Golay J
Blood; 1992 May; 79(10):2708-16. PubMed ID: 1586718
[TBL] [Abstract][Full Text] [Related]
42. The anti-proliferative effect of proliferating cell nuclear antigen-specific antisense oligonucleotides on human gastric cancer cell lines.
Sakakura C; Hagiwara A; Tsujimoto H; Ozaki K; Sakakibara T; Oyama T; Ogaki M; Takahashi T
Surg Today; 1995; 25(2):184-6. PubMed ID: 7772926
[TBL] [Abstract][Full Text] [Related]
43. Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1.
Moon IJ; Choi K; Choi YK; Kim JE; Lee Y; Schreiber AD; Park JG
J Biol Chem; 2000 Feb; 275(7):4647-53. PubMed ID: 10671493
[TBL] [Abstract][Full Text] [Related]
44. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb.
Gewirtz AM; Anfossi G; Venturelli D; Valpreda S; Sims R; Calabretta B
Science; 1989 Jul; 245(4914):180-3. PubMed ID: 2665077
[TBL] [Abstract][Full Text] [Related]
45. c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation.
Piccinini G; Luchetti MM; Caniglia ML; Carossino AM; Montroni M; Introna M; Gabrielli A
J Invest Dermatol; 1996 Jun; 106(6):1281-6. PubMed ID: 8752671
[TBL] [Abstract][Full Text] [Related]
46. Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors.
Reiss K; Cheng W; Kajstura J; Sonnenblick EH; Meggs LG; Anversa P
Am J Physiol; 1995 Sep; 269(3 Pt 2):H943-51. PubMed ID: 7573538
[TBL] [Abstract][Full Text] [Related]
47. Involvement of OP18 in cell proliferation.
Melhem RF; Strahler JR; Hailat N; Zhu XX; Hanash SM
Biochem Biophys Res Commun; 1991 Sep; 179(3):1649-55. PubMed ID: 1930203
[TBL] [Abstract][Full Text] [Related]
48. Gene expression of flap endonuclease-1 during cell proliferation and differentiation.
Kim IS; Lee MY; Lee IH; Shin SL; Lee SY
Biochim Biophys Acta; 2000 Apr; 1496(2-3):333-40. PubMed ID: 10771101
[TBL] [Abstract][Full Text] [Related]
49. Insulin-like growth factor-I receptor in metanephric development.
Kanwar YS; Liu ZZ; Wada J
Contrib Nephrol; 1994; 107():168-73. PubMed ID: 8004964
[No Abstract] [Full Text] [Related]
50. The IGF-I receptor in cell growth, transformation and apoptosis.
Baserga R; Hongo A; Rubini M; Prisco M; Valentinis B
Biochim Biophys Acta; 1997 Jun; 1332(3):F105-26. PubMed ID: 9196021
[No Abstract] [Full Text] [Related]
51. The role of the insulin-like growth factor I receptor in transformation and apoptosis.
Resnicoff M; Baserga R
Ann N Y Acad Sci; 1998 Apr; 842():76-81. PubMed ID: 9599296
[No Abstract] [Full Text] [Related]
52. A 70-kd polypeptide secreted by human peripheral blood mononuclear cells that suppresses proliferation of a human glioblastoma cell line.
Hemesath TJ; Tarasewicz D; O'Neill A; Gulcher JR; Stefansson K
Ann N Y Acad Sci; 1988; 540():333-6. PubMed ID: 3207260
[No Abstract] [Full Text] [Related]
53. Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.
Smith TJ; Janssen JAMJL
Endocr Rev; 2019 Feb; 40(1):236-267. PubMed ID: 30215690
[TBL] [Abstract][Full Text] [Related]
54. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
Kimbrough-Allah MN; Millena AC; Khan SA
Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
[TBL] [Abstract][Full Text] [Related]
55. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
[TBL] [Abstract][Full Text] [Related]
56. Targeting the IGF-1R: The Tale of the Tortoise and the Hare.
Crudden C; Girnita A; Girnita L
Front Endocrinol (Lausanne); 2015; 6():64. PubMed ID: 25964779
[TBL] [Abstract][Full Text] [Related]
57. Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro.
Wahner Hendrickson AE; Haluska P; Schneider PA; Loegering DA; Peterson KL; Attar R; Smith BD; Erlichman C; Gottardis M; Karp JE; Carboni JM; Kaufmann SH
Cancer Res; 2009 Oct; 69(19):7635-43. PubMed ID: 19789352
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells.
Shi P; Chandra J; Sun X; Gergely M; Cortes JE; Garcia-Manero G; Arlinghaus RB; Lai R; Amin HM
J Cell Mol Med; 2010 Jun; 14(6B):1777-92. PubMed ID: 19508387
[TBL] [Abstract][Full Text] [Related]
59. IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
Shi P; Lai R; Lin Q; Iqbal AS; Young LC; Kwak LW; Ford RJ; Amin HM
Blood; 2009 Jul; 114(2):360-70. PubMed ID: 19423729
[TBL] [Abstract][Full Text] [Related]
60. B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.
Douglas RS; Naik V; Hwang CJ; Afifiyan NF; Gianoukakis AG; Sand D; Kamat S; Smith TJ
J Immunol; 2008 Oct; 181(8):5768-74. PubMed ID: 18832736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
